Tag Archives: PSTI

Hot Performing Stocks For 2019

General Electric Company (NYSE:GE) has missed earnings estimate only once in last 26 quarters.
Flickr

Boston, Massachusetts-based industrial giant General Electric Company (NYSE:GE) is scheduled to report its first-quarter 2017 earnings on Friday, 21st April before the market opens. GE has had a rough 2016 with revenues and margins coming under pressure. While GE certainly did not earn any prizes for execution overall, headwinds in the oil & gas segment were mainly to blame for its poor performance. Shares of GE have lost 4% in last one year and are down almost 6% YTD, widely underperforming the S&P 500 (INDEX:SPAL) which has returned more than 10% in the last one year. GE stock has erased most of the post-election gains. GE stock had rallied more than 10% after the elections through mid-December on the hopes that President Trump’s infrastructure plans and loose environmental policies will greatly benefit General Electric Company. The exuberance has cooled down since then.

Hot Performing Stocks For 2019: Trillium Therapeutics Inc.(TRIL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Trillium Therapeutics (TRIL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Shares of Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) have been given an average rating of “Hold” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $10.94.

Hot Performing Stocks For 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

  • [By Ethan Ryder]

    Shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) have earned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $4.13.

Hot Performing Stocks For 2019: Protalix BioTherapeutics, Inc.(PLX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) saw strong trading volume on Wednesday . 3,171,206 shares changed hands during mid-day trading, an increase of 375% from the previous session’s volume of 667,423 shares.The stock last traded at $0.62 and had previously closed at $0.52.

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY NOTICE: “Protalix Biotherapeutics (PLX) Shares Up 6.8%” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at www.tickerreport.com/banking-finance/3355139/protalix-biotherapeutics-plx-shares-up-6-8.html.

  • [By Stephan Byrd]

    PlexCoin (CURRENCY:PLX) traded flat against the US dollar during the 24-hour period ending at 19:00 PM Eastern on August 24th. One PlexCoin token can currently be bought for about $0.0074 or 0.00000111 BTC on popular exchanges. Over the last week, PlexCoin has traded flat against the US dollar. PlexCoin has a total market cap of $0.00 and $7.00 worth of PlexCoin was traded on exchanges in the last 24 hours.

Hot Performing Stocks For 2019: Regional Management Corp.(RM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Regional Management (RM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Enova International (NYSE: ENVA) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Max Byerly]

    Provident Financial (OTCMKTS: FPLPY) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.

  • [By Stephan Byrd]

    Regional Management Corp (NYSE:RM) insider Basswood Capital Management, L bought 14,311 shares of the business’s stock in a transaction dated Monday, June 4th. The shares were bought at an average price of $36.58 per share, with a total value of $523,496.38. The transaction was disclosed in a filing with the SEC, which is available at this link.

  • [By Logan Wallace]

    ValuEngine cut shares of Regional Management (NYSE:RM) from a strong-buy rating to a buy rating in a research note released on Saturday morning.

    Separately, Zacks Investment Research downgraded Regional Management from a buy rating to a hold rating in a research report on Wednesday, March 14th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $29.86.

Hot Performing Stocks For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Avid Bioservices (NASDAQ:CDMO) and ESSA Pharma (NASDAQ:EPIX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Performing Stocks For 2019: United Microelectronics Corporation(UMC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news articles that may have effected Accern Sentiment’s scoring:

    Get United Microelectronics alerts:

    United Microelectronics Corp (UMC) Receives Consensus Recommendation of “Hold” from Analysts (americanbankingnews.com) UMC and Avalanche partner for MRAM development (evertiq.com) INSIGHT-China lures chip talent from Taiwan with fat salaries, perks (news.trust.org) Taiwanese engineers lured to mainland China as chip makers go into overdrive (scmp.com) Eight-inch fab capacity remains tight, says UMC president (digitimes.com)

    A number of research analysts have recently commented on the stock. Mizuho upgraded shares of United Microelectronics from an “underperform” rating to a “neutral” rating in a research report on Monday, July 9th. Morgan Stanley upgraded shares of United Microelectronics from an “underweight” rating to an “equal weight” rating in a research report on Monday, July 2nd. Finally, Sanford C. Bernstein upgraded shares of United Microelectronics from an “underperform” rating to a “market perform” rating and boosted their price target for the company from $2.10 to $2.60 in a research report on Sunday, June 10th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $2.60.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern’s analysis:

    Get United Microelectronics alerts:

    UMC stays focused on profitability (digitimes.com) BRIEF-UMC’s Shareholders Approve Subsidiary Hejian Technology (Suzhou) To Apply For Shanghai Listing (sg.finance.yahoo.com) Shareholders approve Taiwan chipmaker’s Shanghai listing plan (asia.nikkei.com) UMC – United Microelectronics Corporation: UMC Shareholders Approve Agenda Items at Company’s 2018 First Extraordinary General Meeting (twst.com) United Microelectronics Corp (UMC) Short Interest Down 53.5% in July (americanbankingnews.com)

    Several equities analysts recently issued reports on the company. Sanford C. Bernstein raised United Microelectronics from an “underperform” rating to a “market perform” rating and upped their target price for the company from $2.10 to $2.60 in a research report on Sunday, June 10th. Mizuho raised United Microelectronics from an “underperform” rating to a “neutral” rating in a research report on Monday, July 9th. ValuEngine downgraded United Microelectronics from a “buy” rating to a “hold” rating in a research report on Thursday, April 26th. Finally, Morgan Stanley raised United Microelectronics from an “underweight” rating to an “equal weight” rating in a research report on Monday, July 2nd. Five research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $2.60.

  • [By Max Byerly]

    Shares of United Microelectronics Corp (NYSE:UMC) have received a consensus rating of “Hold” from the ten analysts that are currently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $2.19.

  • [By Nicholas Rossolillo]

    Speaking of trade wars, the one looming between the world’s two largest economies, the U.S. and China, has been under the microscope. To kick off July, a court in China suspended sales of 26 products from semiconductor manufacturer Micron Technology (NASDAQ:MU). The Idaho-based maker of memory chips has been embroiled in a patent infringement dispute with Taiwan-based United Microelectronics (NYSE: UMC), and this latest turn is a point in favor of the latter.

  • [By Money Morning News Team]

    United Microelectronics Corp. (NYSE: UMC) is a semiconductor company based in Hsinchu, Taiwan.

    Founded as Taiwan’s first semiconductor company in 1980, UMC is best known for manufacturing integrated circuits used by larger semiconductor companies like Nvidia Corp. (Nasdaq: NVDA) in their products.

Top Value Stocks To Own For 2019

Peapack Gladstone Financial Corp raised its holdings in shares of Alerian MLP (NYSEARCA:AMLP) by 15.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 242,801 shares of the exchange traded fund’s stock after buying an additional 32,485 shares during the quarter. Peapack Gladstone Financial Corp’s holdings in Alerian MLP were worth $2,275,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Alpine Woods Capital Investors LLC increased its position in shares of Alerian MLP by 3.4% during the first quarter. Alpine Woods Capital Investors LLC now owns 150,000 shares of the exchange traded fund’s stock valued at $1,406,000 after purchasing an additional 5,000 shares during the period. American Research & Management Co. increased its position in shares of Alerian MLP by 45.8% during the fourth quarter. American Research & Management Co. now owns 18,075 shares of the exchange traded fund’s stock valued at $195,000 after purchasing an additional 5,675 shares during the period. Westside Investment Management Inc. increased its position in shares of Alerian MLP by 97.9% during the fourth quarter. Westside Investment Management Inc. now owns 12,500 shares of the exchange traded fund’s stock valued at $142,000 after purchasing an additional 6,185 shares during the period. Edge Advisors LLC increased its position in shares of Alerian MLP by 56.8% during the fourth quarter. Edge Advisors LLC now owns 22,785 shares of the exchange traded fund’s stock valued at $245,000 after purchasing an additional 8,251 shares during the period. Finally, Park Avenue Securities LLC increased its position in shares of Alerian MLP by 16.7% during the fourth quarter. Park Avenue Securities LLC now owns 67,392 shares of the exchange traded fund’s stock valued at $745,000 after purchasing an additional 9,650 shares during the period.

Top Value Stocks To Own For 2019: Companhia Brasileira de Distribuicao(CBD)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top Value Stocks To Own For 2019: Targa Resources, Inc.(TRGP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BlackRock Inc. increased its stake in shares of Targa Resources (NYSE:TRGP) by 1.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,211,608 shares of the pipeline company’s stock after acquiring an additional 176,251 shares during the quarter. BlackRock Inc. owned about 0.06% of Targa Resources worth $537,308,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Aperio Group LLC lowered its stake in shares of Targa Resources (NYSE:TRGP) by 16.1% in the first quarter, Holdings Channel reports. The institutional investor owned 99,458 shares of the pipeline company’s stock after selling 19,134 shares during the period. Aperio Group LLC’s holdings in Targa Resources were worth $4,376,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Targa Resources (NYSE:TRGP) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Wednesday.

  • [By Matthew DiLallo]

    Kinder Morgan has already started to capture some of this growth. It’s working with two of the largest natural gas gathering and processing companies in the region –DCP Midstream (NYSE:DCP) and Targa Resources(NYSE:TRGP) — on the Gulf Coast Express pipeline. That $1.7 billion pipeline will have the capacity to move 1.92 BCF/D of natural gas to market centers along the Gulf when it comes online next October. It’s the first of what could be many expansion projects for the company in the region over the next several years.

  • [By Matthew DiLallo]

    There’s just one problem with all that production: It needs to get out of the basin, which is a problem right now sincethere aren’t enough pipelines. Because of that, some of the best ways to play the Permian production boom are pipeline companies. Three perfectly positioned to profit from the Permian boom arePlains All American Pipeline(NYSE:PAA),Targa Resources(NYSE:TRGP), andKinder Morgan(NYSE:KMI).

  • [By Lee Jackson]

    This top energy MLP has had a string of positives lately.Targa Resources Corp (NYSE: TRGP) is a leading provider of midstream services and is one of the largest independent midstream energy companies in North America. Targa owns, operates, acquires and develops a diversified portfolio of complementary midstream energy assets.

Top Value Stocks To Own For 2019: Escalade, Incorporated(ESCA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Escalade (NASDAQ: ESCA) and Sports Direct Intl (OTCMKTS:SDISY) are both consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation.

  • [By Max Byerly]

    ZPR Investment Management purchased a new stake in Escalade, Inc. (NASDAQ:ESCA) in the 1st quarter, according to its most recent filing with the SEC. The fund purchased 11,422 shares of the company’s stock, valued at approximately $156,000.

Top Value Stocks To Own For 2019: Jewett-Cameron Trading Company(JCTCF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Jewett-Cameron Trading Co (NASDAQ:JCTCF) Director Donald M. Boone sold 4,401 shares of the company’s stock in a transaction dated Friday, June 1st. The shares were sold at an average price of $7.89, for a total transaction of $34,723.89. Following the sale, the director now directly owns 1,369,743 shares of the company’s stock, valued at $10,807,272.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

  • [By Max Byerly]

    Media headlines about Jewett-Cameron Trading (NASDAQ:JCTCF) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Jewett-Cameron Trading earned a news impact score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.2200105194978 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top Value Stocks To Own For 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

  • [By Max Byerly]

    Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Top 10 Performing Stocks To Watch For 2018

Pegasystems (NASDAQ:PEGA) is an online CRM (customer relationship manager) that must be doing something right because is up against a much bigger and formidable competitor like Salesforce (NYSE:CRM), as well as other much bigger companies like SAP AG (NYSE:SAP) and Oracle (NYSE:ORCL).

It can be instructive to look at the relative performance. First, the stock price development over the last five years suggests Pegasystems is outperforming Salesforce, although all of this happened just in the last twelve months.

This is somewhat surprising in the light of the fact that Salesforce has been growing revenues at a substantially higher pace, at least over the past five years:

Top 10 Performing Stocks To Watch For 2018: Astrotech Corporation(ASTC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Astrotech Corp (NASDAQ: ASTC) shares shot up 70 percent to $4.83. Astrotech reported that it has completed its successful 1st Detect demo with Department of Homeland Security and Transportation Security Administration personnel.

  • [By Lisa Levin]

    Astrotech Corp (NASDAQ: ASTC) shares shot up 60 percent to $4.37. Astrotech reported that it has completed its successful 1st Detect demo with Department of Homeland Security and Transportation Security Administration personnel.

  • [By William Romov]

    Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.

    Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
    VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
    FXCM Inc. (Nasdaq: GLBR) $1.12 124%
    Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
    ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
    Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
    Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
    LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
    Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
    Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%

    As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.

Top 10 Performing Stocks To Watch For 2018: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Top 10 Performing Stocks To Watch For 2018: Rackspace Hosting Inc(RAX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Rackspace Hosting, Inc. (NYSE: RAX) reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates. Rackspace shares dropped 7.72 percent to $20.80 in the after-hours trading session.

Top 10 Performing Stocks To Watch For 2018: McClatchy Company (MNI)

Advisors’ Opinion:

  • [By Logan Wallace]

    The McClatchy Company (NYSEAMERICAN:MNI) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 855,291 shares, a decrease of 4.6% from the April 13th total of 896,460 shares. Approximately 17.9% of the company’s stock are sold short. Based on an average trading volume of 11,764 shares, the short-interest ratio is currently 72.7 days.

  • [By Douglas A. McIntyre]

    Several large newspaper chains will face the largest increases in newsprint prices in absolute dollars. These are Gannett (NYSE: GCI), tronc (NASDAQ: TRNC), hedge fund owned Digital First Media, which just laid off dozens of people in Denver and on the West Coast, Hearst, Advance Media, McClatchy (NYSE: MNI) and Gatehouse Media. Among them, they own most of the large newspapers in America and hundreds of newspapers in aggregate. Each of these companies has newsprint demand much larger than that of The Tampa Bay Times.

  • [By Douglas A. McIntyre]

    At another of the largest chains, McClatchy Co. (NYSEAMERICAN: MNI), its flagship property, the Sacramento Bee, laid off 15 editorial workers. That may not seem like many, but in an already thinned out newsroom, it is a lot. The layoffs were also the third in just over a year. There were reports that McClatchy also laid off workers at its other West Coast properties.

Top 10 Performing Stocks To Watch For 2018: Credit Suisse Group(CS)

Advisors’ Opinion:

  • [By David Zeiler]

    The federal government’s largesse isn’t restricted to U.S.-based companies, either. Foreign companies, including foreign banks, are also welcome. Credit Suisse Group AG (NYSE ADR: CS) got $225.1 billion, and UBS Group AG (NYSE: UBS) got $249.1 billion.

  • [By Max Byerly]

    AXA (EPA:CS) has been given a €27.50 ($32.74) target price by research analysts at Kepler Capital Markets in a report released on Thursday. The firm presently has a “buy” rating on the stock. Kepler Capital Markets’ price target indicates a potential upside of 20.61% from the company’s current price.

  • [By Money Morning News Team]

    That’s why Krauth predicts the price of gold will hit $1,400 by the end of the year. Many analysts from banks likeCredit SuisseGroup AG (NYSE ADR: CS) even see gold going as high as $1,500.

Top 10 Performing Stocks To Watch For 2018: The Blackstone Group L.P.(BX)

Advisors’ Opinion:

  • [By ]

    The market hasn’t had its needed purge yet says Byron Wien, who is Vice Chairman in the Private Wealth Solutions of Blackstone Group (BX) . “We will retest the February lows [in the markets],” Wien, 86, said on a call Thursday with media. Wien continues to believe the S&P 500 will rally back after testing the lows, charting a path to 3,000 by year end.

  • [By WWW.THESTREET.COM]

    Private equity giant Blackstone (BX) on Saturday announced that Saudi Arabia would invest $20 billion in a new $40 billion infrastructure fund for projects mainly in the United States. On Sunday, Boeing (BA) said it had signed several defense and commercial deals with Saudi Arabia. Trump was referenced in both deal announcements.

  • [By ]

    The Blackstone Group (BX) : “I think this is a terrific buy.”

    Xilinx (XLNX) : “I think it’s time to start getting back into NVIDIA (NVDA) .”

Top 10 Performing Stocks To Watch For 2018: Innovative Industrial Properties, Inc. (IIPR)

Advisors’ Opinion:

  • [By Sean Williams]

    Yet, there are far more ways for investors to “get their fix” of the cannabis industry than by purchasing companies that directly handle the plant. The ancillary market could deliver even more impressive growth, and one such company that may be worth a spot on your radar is real estate investment trust (REIT) Innovative Industrial Properties (NYSE:IIPR).

Top 10 Performing Stocks To Watch For 2018: FLIR Systems, Inc.(FLIR)

Advisors’ Opinion:

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

  • [By Teresa Rivas]

    Flir Systems(FLIR) was the biggest loser in the S&P 500 on Tuesday, but the stock recouped all its losses Wednesday, and then some.

    Getty Images

    Flir Systems gained $2.78, or 8.1%, to close at $36.93.

    The company’sdisappointing fourth-quarter earnings report was forgotten when it announced that the U.S. Coast Guard awarded it a $50 million contract. Flir will provide marine electronics systems for more than 2,000 Coast Guard vessels for its Scalable Integrated Navigation Systems 2 (SINS-2) program over a five-year period, with the option for extended delivery for an additional five years.

    Even before the news, Imperial Capital’sEd Mally was bullish on the stock’s prospects, who raised his price target on the stock by $2, to $38:

    Although we believe that some may still consider Flir as just a premier provider of very high-end cameras in the bellies of Bell Helicopters or border towers in a lumpy government sector, this 35-year-old company is a global leader in thousands of infrared detector cores and thermography equipment markets and also provides lower priced products to commercial and consumer security customers as well as other customers.

    Flir is up 2% so far this year.

    Coty(COTY) was the hottest stock in the S&P 500 yesterday.

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

Top 10 Performing Stocks To Watch For 2018: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

  • [By Lisa Levin]

    Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

    Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

  • [By Cory Renauer]

    Shares of Agenus Inc (NASDAQ:AGEN), a biopharmaceutical company developing cancer therapies, had fallen about 14.5% as of 3:20 p.m. EST on Wednesday. Investors weren’t too thrilled about its cancer vaccine’s recent clinical trial failure.

Top 10 Performing Stocks To Watch For 2018: Alexco Resource Corp(AXU)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Alexco Resource (NYSEMKT: AXU) operates in two segments: an environmental services business and a mining company. Its mining segment explores developments in Canada, while its environmental segment provides consulting and project management services in the United States and Canada. AXU is up over 400% YTD. The stock has been steadily rising since January. It isn’t clear what’s driving AXU upwards, other than general investor speculation. The stock is trading at $1.72 per share as of Monday intraday.

Hot Medical Stocks To Buy For 2019

Portola Pharmaceuticals (NASDAQ:PTLA) could win approvals from the Food and Drug Administration for two important new drugs in the coming year. Its drug betrixaban could become the first of a new class of drugs to be green-lighted for reducing the chance of blood clots forming in acute medically ill patients, and its AndexXa could become the first antidote approved to reverse the effects of top-selling anticoagulants that are already billion-dollar blockbusters.

In this clip from The Motley Fool’s Industry Focus: Healthcarepodcast, analyst Kristine Harjes and contributor Todd Campbell discuss the opportunity ahead for this biotech, and what’s next on deck for investors.

A transcript follows the video.

This podcast was recorded on March 6, 2017.

Kristine Harjes:We havearrived at our lastcompany of the day, which is also this year’sbiggest winner so far, up72%. This is a name that Todd and Italk about a lot. We both really like this company. That isPortola Pharmaceuticals.

Hot Medical Stocks To Buy For 2019: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Rofin-Sinar Technologies (NASDAQ: RSTI) got a boost, shooting up 37 percent to $31.50 as Coherent, Inc. (NASDAQ: COHR) announced its plans to buy Rofin-Sinar Technologies Inc in a deal valued at around $942 million.

  • [By Joseph Griffin]

    Hood River Capital Management LLC decreased its position in shares of Coherent, Inc. (NASDAQ:COHR) by 63.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 69,773 shares of the scientific and technical instruments company’s stock after selling 122,518 shares during the quarter. Hood River Capital Management LLC owned about 0.28% of Coherent worth $13,075,000 as of its most recent SEC filing.

Hot Medical Stocks To Buy For 2019: American Tower Corporation (REIT)(AMT)

Advisors’ Opinion:

  • [By Andy Pai]

    American Tower Corp (NYSE: AMT), a real estate investment trust that owns cell phone towers, has also been one of Akre's most successful investments. Akre has owned shares in the company on and off since 2003. Akre believes American Tower is the ‘bottleneck business' within the wireless telecom industry. Regardless of advances in technology within the industry, network operators are reliant on the towers, giving the owners of cell phone towers the only effective monopoly in the industry.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on American Tower (AMT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund, Tyler Crowe, and Demitrios Kalogeropoulos]

    If you’re looking for new ideas in that second category, you’re in luck. We asked a few of your fellow investors here at The Motley Fool to share their best stock ideas for the long haul. Read on to see how they came up with Nike(NYSE:NKE),Cintas(NASDAQ:CTAS), andAmerican Tower(NYSE:AMT).

Hot Medical Stocks To Buy For 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Best Bank Stocks To Watch Right Now

It’s official: Your browsing history can be sold to advertisers. President Trump on Monday signed a measure reversing rules that would have required internet providers to get consent before selling your browsing history.

The rules had not yet gone into effect, but providers now find themselves with new freedom when it comes to collecting and selling their customers’ data. What does that mean for you?

What identifying information do they have?

Internet providers already collect a lot of information that’s necessary to maintain their networks, like your location and what you’re looking at online.

Many have said they will not use “sensitive” information, like medical records, children’s data and banking details without consent. However a simple browsing history can reveal those personal details, such as symptoms you’ve Googled. There are concerns that it would be possible to identify people based on this detailed information.

According to Dane Jasper, cofounder of Sonic, an independent ISP located in California, an internet provider can infer a lot about you based just on your browsing. In addition to basics like age and gender, they might know who your friends are, if you’re a recovering alcoholic, or where you went to school. In theory, they could create an in-depth profile of you.

Best Bank Stocks To Watch Right Now: Peak Resorts, Inc.(SKIS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Peak Resorts Inc (NASDAQ: SKIS) is projected to report its quarterly earnings at $0.40 per share on revenue of $42.59 million.

    BMC Stock Holdings Inc (NASDAQ: STCK) is expected to post its quarterly earnings at $0.17 per share on revenue of $449.59 million.

Best Bank Stocks To Watch Right Now: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Healthcare shares gained around 0.43 percent in trading on Friday. Meanwhile, top gainers in the sector included DexCom, Inc. (NASDAQ: DXCM), and Array Biopharma Inc (NASDAQ: ARRY).

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By ]

    Some of our newest plays are getting plenty of attention thanks to the biotech buying spree. Array Biopharma (NASDAQ:ARRY) is an instant winner for you thanks to yesterdays 18% pop. And your core holding XBI continues to rake in the gains.

Best Bank Stocks To Watch Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Benzinga News Desk]

    On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link

    ECONOMIC DATA
    March 2017 US Challenger layoffs report 43,310 vs 36,975
    Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate.
    San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
    Data on money supply for the recent week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell
    JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform
    PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight
    Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold
    Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

Best Bank Stocks To Watch Right Now: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

  • [By George Budwell]

    Shares of Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biotech developing treatments for endocrine and metabolic disorders,dropped by 30.1% last month,according toS&P Global Market Intelligence. What’s all the fuss about?

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

Best Bank Stocks To Watch Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.